Key distinction: BPC-157 is not a steroid, not a hormone, and not a growth hormone releasing peptide
Presented for research literature review only Scafidi S et al
Our focus is on simplicity, education, transparency, and real medical follow-up
Other GLP-1 agonists include dulaglutide (Trulicity), liraglutide (Saxenda and Victoza), exenatide (Bydueron and Byetta), semaglutide (Rybelsus), and tirzepatide (Mounjaro)
Side-by-side comparison between a recombinant WT IgG1 Fc fragment and a recombinant analog of efgartigimod (IgG1 Fc fragment with MST/HN) revealed that the binding of MST/HN IgG1 Fc at pH 7.4 (KD of ~1220 nM) is approximately 5-fold weaker than that exhibited by WT IgG1 Fc at pH 6.0 (KD of ~272 nM) [225]
For example, the REWIND trial with dulaglutide included a broader population with cardiovascular risk factors